Episode Details
Back to Episodes
Lilly's AI Drug Discovery Push
Description
Eli Lilly is betting big on AI to revolutionize drug discovery, launching an “App Store” for scientists and building a massive Nvidia-powered data center to fuel innovation. With blockbuster weight-loss drugs like Mounjaro and Foundayo raking in record profits and a $7 billion cash reserve, the company is aggressively diversifying before patents expire in the 2030s. They’re partnering with firms like Charles River and Insilico Medicine, snapping up 11 biotech companies this year—including vaccine developers—to hedge bets and future-proof their pipeline.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/12fae5224a137305